Published in N Z Med J on December 09, 1992
Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health (2005) 1.08
The role of effective communication to enhance participation in screening mammography: a New Zealand case. Int J Environ Res Public Health (2009) 0.80
A profile of prognostic and molecular factors in European and Māori breast cancer patients. BMC Cancer (2010) 0.78
Season of initial discovery of tumour as an independent variable predicting survival in breast cancer. Br J Cancer (1990) 2.55
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46
A syndrome of acute zinc deficiency during total parenteral alimentation in man. Ann Surg (1976) 1.62
Determinants of vitamin D status in older men living in a subtropical climate. Osteoporos Int (2006) 1.60
Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54
The acromegalic rosary. Lancet (1991) 1.43
Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) (1994) 1.40
Variation in receptor status between primary and metastatic breast cancer. Cancer (1983) 1.36
Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res (1983) 1.31
Experimental zoster-like herpes simplex in hairless mice. J Invest Dermatol (1971) 1.30
Does delay in diagnosis of breast cancer affect survival? Breast Cancer Res Treat (1990) 1.21
An unusual cause of hyperinsulinaemic hypoglycaemia syndrome. Diabet Med (2003) 1.12
Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus. Br Med J (Clin Res Ed) (1985) 1.10
Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer (1996) 1.09
Survival of women with node negative breast cancer in the Auckland region. N Z Med J (1996) 1.08
Reliability of steroid hormone receptor assays: an international study. Eur J Cancer Clin Oncol (1983) 1.06
Circulating corticotrophin levels in severe hypopituitarism and in the neonate. Lancet (1973) 1.05
Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status. Breast Cancer Res Treat (1985) 1.02
Association between season of first detection of breast cancer and disease progression. Breast Cancer Res Treat (1987) 1.01
Detection of familial dysalbuminaemic hyperthyroxinaemia. Br Med J (Clin Res Ed) (1985) 1.00
New bioassay for luteinizing hormone. Nature (1973) 0.99
Abnormal insulin-receptor down regulation and dissociation of down regulation from insulin biological action in cultured human tumor cells. Cancer Res (1987) 0.97
Hormone binding by human mammary carcinoma. Cancer Res (1977) 0.94
Seasonal change in the concentration of progesterone receptor in breast cancer. Cancer Res (1990) 0.93
Validation of the redox cytochemical assay for corticotrophin. Clin Endocrinol (Oxf) (1974) 0.93
Progesterone and oestrogen receptors in human breast cancer. Aust N Z J Med (1978) 0.92
Insulin receptor regulation in cultured human tumor cells. Cancer Res (1983) 0.90
Effects of vertical-banded gastroplasty on bone and mineral metabolism in obese patients. Br J Surg (1996) 0.89
Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging. Intern Med J (2003) 0.89
Seasonal changes in serum melatonin in women with previous breast cancer. Br J Cancer (1991) 0.88
Milk alkali syndrome following over-the-counter antacid self-medication. N Z Med J (1986) 0.88
Serum levels of insulin-like growth factor binding protein-3 in benign and malignant breast disease. Aust N Z J Surg (1999) 0.85
Season of tumour detection influences factors predicting survival of patients with breast cancer. Breast Cancer Res Treat (1990) 0.84
Estrogen receptors in bilateral breast cancer. Cancer (1988) 0.83
Miliary tuberculosis with hypercalcaemia and raised vitamin D concentrations. Thorax (1987) 0.83
Blood selenium values in an adult Auckland population group. N Z Med J (1979) 0.82
Correlation between hormone binding and growth response of rat mammary tumor. Cancer Res (1976) 0.81
Evidence for independent regulation of human erythrocyte and adipocyte insulin receptors. Clin Endocrinol (Oxf) (1982) 0.81
Applications of the redox bioassay for luteinizing hormone. Clin Endocrinol (Oxf) (1974) 0.81
Ectopic secretion of ACTH and met-enkephalin from a thymic carcinoid. J Endocrinol Invest (1982) 0.81
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate). Aust N Z J Med (1984) 0.81
Letter: Zinc deficiency and intravenous feeding. Lancet (1975) 0.81
Comparison of the redox bioassay with other assays for luteinizing hormone. J Endocrinol (1976) 0.80
Characteristics of the menstrual cycle at the time of surgery for breast cancer. Br J Cancer (1997) 0.80
Acute retinal pigment epitheliitis associated with intravenous bisphosphonate. Br J Ophthalmol (2006) 0.80
Height-related risk factors for prostate cancer. Br J Cancer (2000) 0.80
Experience with a short test of pituitary-adrenal function. Aust N Z J Med (1973) 0.80
Zinc and copper in human nutrition. J Hum Nutr (1981) 0.79
Effect of breast surgery on serum levels of insulin-like growth factors (IGF-I, IGF-II, and IGF binding protein-3) in women with benign and malignant breast lesions. Ann Surg Oncol (2001) 0.79
Insulin binding by normal and neoplastic colon tissue. Int J Cancer (1985) 0.78
Seasonal variation in the secretion of mammotrophic hormones in normal women and women with previous breast cancer. Breast Cancer Res Treat (1997) 0.78
Regulation of insulin binding to human mammary carcinoma. Cancer Res (1982) 0.78
Acute zinc deficency in man during intravenous alimentation. Aust N Z J Surg (1975) 0.78
Insulin receptors in human cancer. Br J Cancer (1981) 0.78
Technical aspects of the redox bioassay for luteinizing hormone. Clin Endocrinol (Oxf) (1974) 0.78
The effect of extradural blockage upon glucose and urea kinetics in surgical patients. Surg Gynecol Obstet (1987) 0.77
Serum IGF-I levels are similar in Samoan, Māori and European populations despite differences in body composition. Growth Horm IGF Res (2006) 0.77
Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD. Br J Radiol (1987) 0.77
Parathyroid cyst with recurrent vocal cord paresis. Aust N Z J Surg (1993) 0.77
A familial syndrome of cardiac myxomas, myxoid neurofibromata, cutaneous pigmented lesions, and endocrine abnormalities. Aust N Z J Med (1986) 0.76
Incidence and clinical features of breast cancer in the Auckland region. N Z Med J (1992) 0.76
Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand. Breast Cancer Res Treat (1987) 0.76
High peripheral and axial bone densities in a postmenopausal woman with untreated hypoparathyroidism. Postgrad Med J (1990) 0.76
The effect of an aldosterone antagonist upon the electrolyte response to surgical trauma. Br J Surg (1968) 0.76
Treatment of breast cancer in the Auckland region 1976-85. N Z Med J (1994) 0.76
The serum prolactin level in testicular tumours--a new tumour marker? Aust N Z J Surg (1980) 0.76
Objective assessment of treatment response in hirsutism. Horm Res (1985) 0.76
Cutaneous insulin allergy responsive to oral desensitisation and aspirin. Br Med J (Clin Res Ed) (1984) 0.75
Watery diarrhoea syndrome with episodic hypercalcaemia. Aust N Z J Med (1977) 0.75
Elevated thyroid hormone levels with normal or raised thyroid-stimulating hormone: a diagnostic and therapeutic dilemma. Intern Med J (2001) 0.75
Hypercalcaemia during resolution of calcinosis in juvenile dermatomyositis. Br Med J (Clin Res Ed) (1984) 0.75
Comparison of two low-dose calcium infusion schedules for localization of insulinomas by selective pancreatic arterial injection with hepatic venous sampling for insulin. Clin Endocrinol (Oxf) (2013) 0.75
Clinical applications of receptor measurements in breast cancer. Br J Cancer (1980) 0.75
Effect of cyproterone acetate on glucocorticoid secretion in patients treated for hirsutism. Acta Endocrinol (Copenh) (1983) 0.75
Low thyroxine levels in some hyperprolactinemic patients due to dopaminergic suppression of thyrotropin. J Clin Endocrinol Metab (1984) 0.75
Steroid hormone receptors in breast tumours presenting during pregnancy or lactation. J Surg Oncol (1984) 0.75
Estrogen receptor status, adrenal androgens and 7 alpha-hydroxydehydroepiandrosterone in breast cancer patients. Eur J Cancer Clin Oncol (1984) 0.75
Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen. Aust N Z J Surg (1981) 0.75
Predicting treatment response in breast cancer using urinary discriminant ratio and receptor assay. Eur J Cancer Clin Oncol (1981) 0.75
51Cr release microassays for histocompatibility antigens on normal and malignant cells. Transplantation (1973) 0.75
Investigation and treatment of renal calculi associated with hypercalciuria. J Endocrinol Invest (1983) 0.75
Criteria for cure in acromegaly: report of a case apparently cured in which persisting tumor was found at autopsy. Neurosurgery (1984) 0.75